5 Results for "

D-2-Amino-5-phosphonovaleric acid

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "D-2-Amino-5-phosphonovaleric acid" in MCE Product Catalog:

37
37 Cited Publications
Cat. No.: HY-100714A
CAS No.: 79055-68-8
Purity:  99.94%
Synonyms: D-APV; D-2-Amino-5-phosphonovaleric acid
Target:  

iGluR

Research Areas:  

Neurological Disease

D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors .
loading...
    loading...
Cat. No.: HY-P10341
CAS No.: 1345835-12-2
Target:  

GCGR

Research Areas:  

Metabolic Disease

ZP3022 is a dual agonist of glucagon-like peptide-1 (GLP-1) and gastrin that has the ability to sustainably improve glycemic control. Additionally, ZP3022 can effectively increase β-cell mass, promote β-cell proliferation, and enhance the function of pancreatic islets. ZP3022 can be used in anti-diabetic research .
loading...
    loading...
Cat. No.: HY-P11243
Target:  

Ephrin Receptor

Research Areas:  

Neurological Disease

EphA4 agonist compound 23 is a novel EphA4 agonist peptide mimic. EphA4 agonist compound 23 exhibits high affinity, high selectivity, and significant receptor activation ability. EphA4 agonist compound 23 is commonly used in the study of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-100714AR
CAS No.: 79055-68-8
Synonyms: D-APV (Standard); D-2-Amino-5-phosphonovaleric acid (Standard)
Research Areas:  

Neurological Disease

D-AP5 (Standard) is the analytical standard of D-AP5 (HY-100714A). This product is intended for research and analytical applications. D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors .
loading...
    loading...
Cat. No.: HY-P10876
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

mcK6A1 is an inhibitor for the aggregation of amyloid-β (), that selectively binds to the 16KLVFFA21 segment of Aβ42, forms an extended β-folded structure, and inhibits the formation of Aβ42 oligomers. mcK6A1 can be used in research of Alzheimer's disease and other amyloid-related diseases .
loading...
    loading...